Invention Grant
- Patent Title: Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
-
Application No.: US12683341Application Date: 2010-01-06
-
Publication No.: US07972801B2Publication Date: 2011-07-05
- Inventor: M. Zouhair Atassi
- Applicant: M. Zouhair Atassi
- Applicant Address: US CA Irvine US TX Houston
- Assignee: Allergan, Inc.,Baylor College of Medicine
- Current Assignee: Allergan, Inc.,Baylor College of Medicine
- Current Assignee Address: US CA Irvine US TX Houston
- Agent Kenton Abel; Zouhair M. Atassi; Debra Condino
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
The present invention provides BoNT/B peptides, BoNT/B peptide compositions, tolerogizing compositions, immune response inducing compositions, as well as methods of determining immunoresistance to botulinum toxin therapy in an individual, methods of treating immunoresistance to botulinum toxin therapy in an individual, methods of reducing anti-botulinum toxin antibodies in an individual and methods of inducing a BoNT/B immune response an individual.
Public/Granted literature
- US20100112082A1 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides Public/Granted day:2010-05-06
Information query
IPC分类:
